Aemetis recognizes two reportable geographic segments: North America and India. The North America operating segment includes the Keyes Plant in Keyes, the cellulosic ethanol facility in Riverbank, the cluster of biogas digesters on dairies near the Keyes Plant, the Goodland Plant in Kansas, and the research and development facility in Minnesota. The India operating segment includes the Companys 50 million gallon per year nameplate capacity biodiesel manufacturing plant (Kakinada Plant), the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius. The Companys biodiesel is marketed and sold primarily to customers in India through brokers and by the Company directly. Summarized financial information by reportable segment for the three and nine months ended September 30, 2019 and 2018 follows: Three months ended September 30, 2019 Three months ended September 30, 2018 North America India Total Consolidated North America India Total Consolidated Revenues $ 37,820 $ 19,569 $ 57,389 $ 38,576 $ 6,059 $ 44,635 Cost of goods sold 37,990 15,417 53,407 36,147 5,820 41,967 Gross profit (loss) (170 ) 4,152 3,982 2,429 239 2,668 Other Expenses Research and development expenses 37 - 37 74 - 74 Selling, general and administrative expenses 2,716 1,813 4,529 3,645 248 3,893 Interest expense 6,293 49 6,342 5,261 150 5,411 Accretion of Series A preferred units 589 - 589 - - - Other income (265 ) (24 ) (289 ) (55 ) (6 ) (61 ) Income (loss) before income taxes $ (9,540 ) $ 2,314 $ (7,226 ) $ (6,496 ) $ (153 ) $ (6,649 ) Capital expenditures $ 3,664 $ 351 $ 4,015 $ 703 $ 24 $ 727 Depreciation 942 161 1,103 992 166 1,158 For the nine months ended September 30, 2019 For the nine months ended September 30, 2018 North America India Total Consolidated North America India Total Consolidated Revenues $ 113,942 $ 35,954 $ 149,896 $ 115,380 $ 17,301 $ 132,681 Cost of goods sold 113,440 29,552 142,992 109,208 16,171 125,379 Gross profit 502 6,402 6,904 6,172 1,130 7,302 Other Expenses Research and development expenses 160 - 160 191 - 191 Selling, general and administrative expenses 9,972 2,743 12,715 10,580 709 11,289 Interest expense 18,805 332 19,137 19,344 446 19,790 Accretion of Series A preferred units 1,509 - 1,509 - - - Loss contingency on litigation 6,200 - 6,200 - - - Other expense (income) (228 ) (773 ) (1,001 ) (12 ) 14 2 Income (loss) before income taxes $ (35,916 ) $ 4,100 $ (31,816 ) $ (23,931 ) $ (39 ) $ (23,970 ) Capital expenditures $ 4,249 $ 804 $ 5,053 $ 1,760 $ 738 $ 2,498 Depreciation 2,883 454 3,337 2,976 481 3,457 North America. During the three and nine months ended September 30, 2019, the Companys revenues from ethanol, WDG, and corn oil were earned pursuant to the Corn Procurement and Working Capital Agreement established between the Company and J.D. Heiskell. Sales of ethanol, WDG, and corn oil to J.D. Heiskell accounted for 98.3% and 99.3% of the Companys North America segment revenues for the three and nine months ended September 30, 2019, respectively. During the three and nine months ended September 30, 2018, the Companys revenues from ethanol, WDG, and corn oil were earned pursuant to the Corn Procurement and Working Capital Agreement established between the Company and J.D. Heiskell. Sales of ethanol, WDG, and corn oil to J.D. Heiskell accounted for 99.8% and 99.6% of the Companys North America segment revenues for the three and nine months ended September 30, 2018, respectively. India . During the three months ended September 30, 2019, three biodiesel customers accounted for 41%, 16%, and 15% and no refined glycerin customers accounted for more than 10% of the Companys consolidated India segment revenues, compared to two biodiesel customers accounting for 57% and 18% and no refined glycerin customers accounting for more than 10% of consolidated India segment revenues during the three months ended September 30, 2018. During the nine months ended September 30, 2019, three biodiesel customers accounted for 29%, 18%, and 15% and no refined glycerin customers accounted for more than 10% of consolidated India segment revenues, compared to two biodiesel customers accounted for 55% and 13% and no refined glycerin customers accounted for more than 10% of consolidated India segment revenues during the nine months ended September 30, 2018. Total assets consist of the following: As of September 30, December 31, 2019 2018 North America $ 79,180 $ 78,149 India 17,503 13,672 Total Assets $ 96,683 $ 91,821